Meta-analyses indicate that GLP-1RAs generally reduce HOMA-IR and improve fasting blood glucose and 2 h OGTT levels in the PCOS population (78)
Jayne Hornung, chief clinical officer at Managed Markets Insight and Technology, suggests initial pricing of oral GLP-1s for weight loss could be reminiscent of the early days of anti-CGRP medications for migraines when the first oral CGRP came to market in 2019, the pricing still remained high
The skincare forums are dotted with similar stories - people who tried copper peptides expecting firmer, younger-looking skin and ended up with the opposite
Research shows that people who stop GLP-1 medications after losing weight often regain a significant portion of it
The practical answer is: optimize for muscle first, ketosis second
However, like all medications, it can interact with other drugs, which can affect how Acetyl-L-Carnitine HCl works or increase the risk of side effects